ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,440,929,773 | +23.9% | 4,964,973 | -1.8% | 0.21% | +27.9% |
| Q2 2023 | $1,970,374,883 | -49.5% | 5,055,743 | -51.7% | 0.16% | -7.3% |
| Q1 2023 | $3,899,793,096 | +97.6% | 10,466,996 | +100.9% | 0.18% | -9.2% |
| Q4 2022 | $1,973,389,475 | +7.8% | 5,209,169 | +0.5% | 0.20% | +2.6% |
| Q3 2022 | $1,830,823,000 | -2.9% | 5,185,732 | +4.2% | 0.19% | +1.6% |
| Q2 2022 | $1,884,680,000 | +27.7% | 4,974,343 | +6.3% | 0.19% | +59.3% |
| Q1 2022 | $1,475,688,000 | -8.1% | 4,680,115 | +2.0% | 0.12% | -0.8% |
| Q4 2021 | $1,606,111,000 | +19.2% | 4,586,399 | +2.8% | 0.12% | +11.2% |
| Q3 2021 | $1,347,043,000 | -4.0% | 4,460,413 | -4.3% | 0.11% | -2.7% |
| Q2 2021 | $1,403,336,000 | +9.0% | 4,661,162 | -0.3% | 0.11% | 0.0% |
| Q1 2021 | $1,287,093,000 | -7.2% | 4,673,710 | -0.9% | 0.11% | -10.6% |
| Q4 2020 | $1,386,398,000 | +12.7% | 4,714,197 | +0.6% | 0.12% | -0.8% |
| Q3 2020 | $1,230,078,000 | +16.8% | 4,685,655 | +0.2% | 0.12% | +6.9% |
| Q2 2020 | $1,053,593,000 | +88.1% | 4,677,855 | +10.0% | 0.12% | +48.7% |
| Q1 2020 | $560,038,000 | -17.8% | 4,251,407 | +0.2% | 0.08% | +4.0% |
| Q4 2019 | $681,337,000 | +58.1% | 4,244,563 | +12.2% | 0.08% | +44.2% |
| Q3 2019 | $431,071,000 | -17.3% | 3,782,652 | +2.8% | 0.05% | -14.8% |
| Q2 2019 | $521,146,000 | +12.8% | 3,680,930 | -0.5% | 0.06% | +10.9% |
| Q1 2019 | $461,903,000 | +37.9% | 3,699,956 | +6.1% | 0.06% | +19.6% |
| Q4 2018 | $335,001,000 | +27.1% | 3,487,052 | +0.3% | 0.05% | +53.3% |
| Q3 2018 | $263,548,000 | +2.8% | 3,475,049 | +12.3% | 0.03% | 0.0% |
| Q2 2018 | $256,400,000 | +3.5% | 3,094,388 | +0.5% | 0.03% | +3.4% |
| Q1 2018 | $247,723,000 | +163.1% | 3,079,597 | +106.5% | 0.03% | +163.6% |
| Q4 2017 | $94,144,000 | +456.5% | 1,491,031 | +97.8% | 0.01% | +450.0% |
| Q3 2017 | $16,917,000 | +5.8% | 753,892 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,990,000 | – | 753,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |